Monoclonal Antibody 95-5-49

Monoclonal Antibody 95-5-49 appears to be a code name for an investigational monoclonal antibody. There is no evidence in the provided sources or major public databases that this specific antibody has been approved, marketed, or widely studied in clinical trials as of May 2025. Its mechanism of action, target antigen, developer, and primary indication are not specified in the available literature. In general, monoclonal antibodies are large protein molecules designed to bind with high specificity to particular antigens and can be used for a variety of therapeutic purposes including cancer therapy, autoimmune diseases, infectious diseases, and more[1][3][7]. Without further information on its target or context of use, no additional details about this specific antibody can be provided.